Skip to content

State of Play of Non-tuberculous Mycobacteria in Alsace

State of Play of Non-tuberculous Mycobacteria in Alsace: a Retrospective Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06185166
Acronym
Mycoba
Enrollment
100
Registered
2023-12-29
Start date
2022-12-05
Completion date
2024-06-05
Last updated
2023-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Tuberculous Mycobacteria

Keywords

Non-Tuberculous Mycobacteria

Brief summary

Non-tuberculous mycobacteriosis (NTM) are infectious diseases caused by mycobacteria that are not part of the Tuberculosis complex. More than 190 species have been identified to date. As an environmental reservoir, it most often affects the lungs, skin and soft tissues, lymph nodes, but it can affect all organs. Varying in virulence depending on the species, most infections do not cause illness. There is currently no coordinated care pathway for this pathology in Alsace. The means necessary to set up such a structure requires knowing the importance of the disease.

Detailed description

The aim of the study is to determine the incidence of non-tuberculous mycobacterial infections in the ALSACE region, the proportion of cases in which the infection causes illness, and its evolution over time.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Adult subject (≥ 18 years old) * in whom a biological sample is culture positive for a non-tuberculous mycobacterium * born in France and domiciled in Alsace (i.e. whose home postal code begins with 67 or 68) * not opposing the reuse of its data for scientific research purposes

Exclusion criteria

* Subject having expressed opposition to participating in the study * not domiciled in Alsace * Born abroad * Isolation of a mycobacterium from the Tuberculosis complex and Mycobacterium gordonae

Design outcomes

Primary

MeasureTime frame
Retrospective description of non-tuberculous mycobacteria in AlsaceThrough study completion, an average of 6 months

Countries

France

Contacts

Primary ContactLoïc KASSEGNE, MD
loic.kassegne@chru-strasbourg.fr33 3 69 55 01 88

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026